SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017440
Filing Date
2022-11-10
Accepted
2022-11-10 16:30:48
Documents
75
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bcel-20220930x10q.htm   iXBRL 10-Q 2176104
2 EX-31.1 bcel-20220930xex31d1.htm EX-31.1 12784
3 EX-31.2 bcel-20220930xex31d2.htm EX-31.2 12368
4 EX-32.1 bcel-20220930xex32d1.htm EX-32.1 8228
  Complete submission text file 0001558370-22-017440.txt   7604553

Data Files

Seq Description Document Type Size
5 EX-101.SCH bcel-20220930.xsd EX-101.SCH 46440
6 EX-101.CAL bcel-20220930_cal.xml EX-101.CAL 47796
7 EX-101.DEF bcel-20220930_def.xml EX-101.DEF 220344
8 EX-101.LAB bcel-20220930_lab.xml EX-101.LAB 373860
9 EX-101.PRE bcel-20220930_pre.xml EX-101.PRE 341083
69 EXTRACTED XBRL INSTANCE DOCUMENT bcel-20220930x10q_htm.xml XML 1318191
Mailing Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070 650-595-2595
Atreca, Inc. (Filer) CIK: 0001532346 (see all company filings)

IRS No.: 273723255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38935 | Film No.: 221377783
SIC: 2834 Pharmaceutical Preparations